alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit
10.52


 


AGREEMENT


 


This
AGREEMENT (this “Agreement”) is entered into as of December 6, 2022, by and among BioLife4D Corporation, a Delaware corporation
(the “Company”), and BioLife4D - SM Trust (the “Trust”).


 


WHEREAS,
the Company has become indebted to Fifth Third Bank National Association (the “Bank”) pursuant to a loan made by the
Bank to the Company in the original principal amount of $500,000 (the “Loan”);


 


WHEREAS,
as a condition to the Bank’s agreement to make the Loan to the Company, the Trust has provided cash collateral to secure the
Loan in the amount of $500,000 (the “Collateral”); and


 


WHEREAS,
in consideration of the Trust providing the Collateral to the Bank in connection with the Loan, the Company has agreed to reimburse
the Trust for all interest, costs, expenses and other amounts incurred by the Trust in connection with the Loan and the provision of
the Collateral.


 


NOW,
THEREFORE, in consideration of the mutual covenants and agreements set forth in this Agreement, and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Trust hereby agree as follows:


 


1. Reimbursement.
In the event that the Trust incurs any interest, costs, expenses and other amounts in connection with the Loan (the “Trust
Costs”), the Company shall, within five days following written request from the Trust, reimburse the Trust for any and all Trust
Costs. The Trust shall provide the Company with reasonable documentation evidencing all such Trust Costs.


 


2. Authority.
The Company has the full authority to execute, deliver, and perform under this Agreement and this Agreement constitutes the legal,
valid, and binding obligation of the Company.


 


3. Governing
Law. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of law principles
that would result in the application of any law other than the law of the State of Delaware.


 


4. Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute
one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature
complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered
shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.


 


[Signature
page follows.]


 




    	 



     


    

 


IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.


 


	BIOLIFE4D
    - SM TRUST	 	BIOLIFE4D
    CORPORATION
	 	 	 	 	 
	By:	/s/
    Steven R. Morris	 	By:	/s/
    Steven R. Morris
	Name: 	 Steven R. Morris	 	Name:	 Steven R. Morris
	Title:	Trustee	 	Title:	CEO


 


[Signature
Page to Agreement]
| **Exhibit 23.1**

**Consent of Ernst & Young LLP, Independent Auditors**

We consent to the incorporation by reference in the Registration Statements No. 33-47479,33-97710, 333-10681, 333-87908, 333-18347, 333-55821, 333-57621, 333-70391, and333-33390 of our report dated March 14, 2003, with respect to the consolidatedfinancial statements of Palomar Medical Technologies, Inc. included in the AnnualReport (Form 10-K) for the year ended December 31, 2002.

Boston, MassachusettsMarch 24, 2003 |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
II 

Calendar No. 238 

117TH CONGRESS 

2D SESSION S. 3458 

To amend title 18, United States Code, to provide enhanced penalties for 

convicted murderers who kill or target America’s public safety officers. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 10, 2022 

Mr. TOOMEY (for himself, Mr. TILLIS, Mr. COTTON, Mr. JOHNSON, Mr. 

HOEVEN, Mr. BRAUN, Mrs. CAPITO, Mr. INHOFE, Ms. ERNST, Mr. 

BLUNT, Mr. THUNE, Mrs. BLACKBURN, Mr. RUBIO, Mr. SCOTT of Florida, Mr. ROUNDS, and Mr. TUBERVILLE) introduced the following bill; 

which was read the first time 

JANUARY 18, 2022 

Read the second time and placed on the calendar 

A BILL 

To amend title 18, United States Code, to provide enhanced 

penalties for convicted murderers who kill or target 

America’s public safety officers. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Thin Blue Line Act’’. 


kjohnson on DSK79L0C42PROD with BILLS
2 

•S 3458 PCS

1 SEC. 2. AGGRAVATING FACTORS FOR DEATH PENALTY. 

2 (a) IN GENERAL.—Section 3592(c) of title 18, 

3 United States Code, is amended by inserting after para4 graph (16) the following: 

5 ‘‘(17) KILLING OR TARGETING OF LAW EN6 FORCEMENT OFFICER.— 

7 ‘‘(A) The defendant killed or attempted to 

8 kill, in the circumstance described in subpara9 graph (B), a person who is authorized by law— 

10 ‘‘(i) to engage in or supervise the pre11 vention, detention, investigation, or pros12 ecution, or the incarceration of any person 

13 for any criminal violation of law; 

14 ‘‘(ii) to apprehend, arrest, or pros15 ecute an individual for any criminal viola16 tion of law; or 

17 ‘‘(iii) to be a firefighter or other first 

18 responder. 

19 ‘‘(B) The circumstance referred to in sub20 paragraph (A) is that the person was killed or 

21 targeted— 

22 ‘‘(i) while he or she was engaged in 

23 the performance of his or her official du24 ties; 

25 ‘‘(ii) because of the performance of his 

26 or her official duties; or 


kjohnson on DSK79L0C42PROD with BILLS
3 

•S 3458 PCS

1 ‘‘(iii) because of his or her status as 

2 a public official or employee.’’. 

3 (b) EFFECTIVE DATE.—The amendment made by 

4 subsection (a) shall take effect on the date that is 30 days 

5 after the date of enactment of this Act. 


kjohnson on DSK79L0C42PROD with BILLS
Calendar No. 238 

117TH CONGRESS 

2D SESSION S. 3458 

A BILL 

To amend title 18, United States Code, to provide 

kill or target America’s public safety officers. enhanced penalties for convicted murderers who 

JANUARY 18, 2022 

Read the second time and placed on the calendar 


kjohnson on DSK79L0C42PROD with BILLS
II 

117TH CONGRESS 

2D SESSION S. 3604 

To prohibit Federal funds from being made available to any preschool, kindergarten, elementary school, or secondary school that has a face mask 

mandate. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 9, 2022 

Mr. COTTON introduced the following bill; which was read twice and referred 

to the Committee on Health, Education, Labor, and Pensions 

A BILL 

To prohibit Federal funds from being made available to 

any preschool, kindergarten, elementary school, or secondary school that has a face mask mandate. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Unmask Our Kids Act 

5 of 2022’’. 

6 SEC. 2. REQUIREMENT TO RESCIND SCHOOL FACE MASK 

7 MANDATES TO RECEIVE FEDERAL FUNDING. 

8 (a) DEFINITIONS.—In this section, the terms ‘‘ele9 mentary school’’, ‘‘local educational agency’’, ‘‘Secretary’’, 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•S 3604 IS

1 and ‘‘State educational agency’’ have the meanings given 

2 the terms in section 8101 of the Elementary and Sec3 ondary Education Act of 1965 (20 U.S.C. 7801). 

4 (b) REQUIREMENT TO RESCIND SCHOOL MASK MAN5 DATES TO RECEIVE FEDERAL FUNDING.—No Federal 

6 funds shall be made available to any preschool, kinder7 garten, elementary school, or secondary school that— 

8 (1) mandates that students wear face masks 

9 while on school grounds or engaged in school-spon10 sored activities; or 

11 (2) limits participation in school activities for 

12 students who voluntarily elect not to wear a face 

13 mask on school grounds or while engaged in school14 sponsored activities. 

15 (c) ENSURING COMPLIANCE.—The Secretary shall 

16 require each application for Federal assistance submitted 

17 to the Secretary by a State educational agency or local 

18 educational agency to attest that all preschools, kinder19 gartens, elementary schools, and secondary schools receiv20 ing Federal funds served by the agency have rescinded any 

21 face mask mandate. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS
[Federal Register Volume 60, Number 247 (Tuesday, December 26, 1995)]
[Notices]
[Page 66823]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31341]








Nuclear Regulatory Commission

DATE: Weeks of December 25, 1995 and January 1, 8 and 15, 1996.

PLACE: Commissioners' Conference Room, 11555 Rockville Pike, Rockville, 
Maryland.

STATUS: Public.

MATTERS TO BE CONSIDERED:

Week of December 25--Tentative

    There are no meetings scheduled for the Week of December 25.

Week of January 1--Tentative

Friday, January 5

10:00 a.m.
    Briefing by NRC Staff on Industry Restructuring and Deregulation 
        (Public Meeting) (Contact: Scott Newberry, 301-415-1183)

Week of January 8--Tentative

    There are no meetings scheduled for the Week of January 8.

Week of January 15--Tentative

    There are no meetings scheduled for the Week of January 15.

    Note: the Nuclear Regulatory Commission is operating under a 
delegation of authority to Chairman Shirley Ann Jackson, because 
with three vacancies on the Commission, it is temporarily without a 
quorum. As a legal matter, therefore, the Sunshine Act does not 
apply; but in the interests of openness and public accountability, 
the Commission will conduct business as though the Sunshine ACt were 
applicable.

    The schedule for Commission meetings is subject to change on short 
notice. To verify the status of meetings call (Recording)--(301) 415-
1292.

CONTACT PERSON FOR MORE INFORMATION: Bill Hill (301) 415-1661.

* * * * *

    This notice is distributed by mail to several hundred subscribers; 
if you no longer wish to receive it, or would like to be added to it, 
please contact the Office of the Secretary, Attn: Operations Branch, 
Washington, D.C. 20555 (301-415-1963).
    In addition, distribution of this meeting notice over the internet 
system is available. If you are interested in receiving this Commission 
meeting schedule electronically, please send an electronic message to 
<a href="/cdn-cgi/l/email-protection#fd9c919fbd938f9ed39a928b"><span class="__cf_email__" data-cfemail="9ffef3fddff1edfcb1f8f0e9">[email protected]</span></a> or <a href="/cdn-cgi/l/email-protection#593e322d19372b3a773e362f"><span class="__cf_email__" data-cfemail="b7d0dcc3f7d9c5d499d0d8c1">[email protected]</span></a>.

* * * * *

    Dated: December 20, 1995.
William M. Hill, Jr.,

SECY Tracking Officer, Office of the Secretary.

[FR Doc. 95-31341 Filed 12-21-95; 2:02 pm]

BILLING CODE 7590-01-M

</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
II 

117TH CONGRESS 

1ST SESSION S. 3437 

To extend certain COVID–19 bankruptcy relief provisions through March 

27, 2022. 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 18 (legislative day, DECEMBER 17), 2021 

Mr. DURBIN (for himself and Mr. GRASSLEY) introduced the following bill; 

which was read twice, considered, read the third time, and passed 

A BILL 

To extend certain COVID–19 bankruptcy relief provisions 

through March 27, 2022. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘COVID-19 Bankruptcy 

5 Relief Extension Consolidation Act of 2021’’. 

6 SEC. 2. EXTENSIONS. 

7 Section 1001 of division FF of the Consolidated Ap8 propriations Act, 2021 (Public Law 116–260; 124 Stat. 

9 3216) is amended by striking ‘‘the date that is 1 year after 


dlhill on DSK120RN23PROD with BILLS
2 

•S 3437 CPS

1 the date of enactment of this Act’’ each place the term 

2 appears and inserting ‘‘March 27, 2022’’. 

Æ 


dlhill on DSK120RN23PROD with BILLS
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 96-6604
VERNON EGGLESTON, Plaintiff - Appellant, versus C. E. BURCH; F. R. POOLE; R. W. ARTHUR, Defendants - Appellees.
Appeal from the United States District Court for the Western District of Virginia, at Roanoke. Jackson L. Kiser, Chief District Judge. (CA-95-881-R) Submitted: September 5, 1996 Decided: September 17, 1996 Before WIDENER and WILKINS, Circuit Judges, and PHILLIPS, Senior Circuit Judge. Affirmed by unpublished per curiam opinion. Vernon Eggleston, Appellant Pro Se. Mark Ralph Davis, OFFICE OF THE ATTORNEY GENERAL OF VIRGINIA, Richmond, Virginia, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Appellant appeals from the district court's order denying relief on his 42 U.S.C. § 1983 (1988) complaint. We have reviewed the record and the district court's opinion and find no reversible error. Accordingly, we affirm on the reasoning of the district court. Eggleston v. Burch , No. CA-95-881-R (W.D. Va. Mar. 29, 1996). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
| Skip to contentSocial Security Online | Actuarial Publications |
|---------------------------------------|------------------------|

| www.socialsecurity.gov | Home  FAQs  Contact Us  Search | **Search**  |
|------------------------|-----------------------------------------------------------------|------------------|

| Solvency provisions | Summary Measures and Graphs |
|---------------------|-----------------------------|

| Trust Fund Investment in Equities | Description of Proposed Provision:      Invest 40 percent of the Trust Funds in equities (phased in 2010-2024), assuming an ultimate 2.9 percent real rate of return on equities, the same as the assumed ultimate yield on the special-issue Social Security trust fund bonds |
|-----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                   |

*Estimates based on the intermediate assumptions        of the 2009 Trustees Report*

|  |  |
|--|--|

|        |
|--------|
|   | Privacy Policy      | Website Policies        & Other Important Information      | Site Map     Last reviewed or modified August 26, 2009 |
[Federal Register Volume 81, Number 24 (Friday, February 5, 2016)]
[Notices]
[Page 6325]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02251]


=======================================================================
-----------------------------------------------------------------------

SURFACE TRANSPORTATION BOARD


Release of Waybill Data

    The Surface Transportation Board has received a request from the 
Association of American Railroads. (WB463-18-1/15/16) for permission to 
use certain data from the Board's 2014 Carload Waybill Sample. A copy 
of this request may be obtained from the Office of Economics.
    The waybill sample contains confidential railroad and shipper data; 
therefore, if any parties object to these requests, they should file 
their objections with the Director of the Board's Office of Economics 
within 14 calendar days of the date of this notice. The rules for 
release of waybill data are codified at 49 CFR 1244.9.
    Contact: Alexander Dusenberry, (202) 245-0319.

Brendetta S. Jones,
Clearance Clerk.
[FR Doc. 2016-02251 Filed 2-4-16; 8:45 am]
BILLING CODE 4915-01-P
Exhibit 31.1
       a)
    
    Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us
by others within those entities, particularly during the period in which this report is
being prepared;b)
    
    Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally accepted
accounting principles;c)
    
    Evaluated the effectiveness of the registrants disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such
evaluation; andd)
    
    Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrants internal control
over financial reporting; and
  a)
    
    All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize, and report financial information;
andb)
    
    Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
  /s/ Victor Viegas

Victor ViegasInterim Chief Executive Officer
1 ... T h i s pr oce edi n g a r i s es ou t of Cau s e N o. 2009- CI

- 10922, s t y l ed James P l ace and G er r y Saum v . Pene l ope F a n n in g , et a l. , i n t he 7 3 rd Jud i ci al D i st ri ct C o urt , B exar C o unt y , T exas , t he H o no rable R enée F

. M cE l haney, presi d i ng. H owever , t he order comp l ai ned of was s i gn ed by t he H onorabl e Jan et Li t t l ej ohn, pres i di ng j udge of t he 15 0t h J udi ci al D istric t C o u rt, B e x a r C o u n ty, T e x a s. 

### i i i i i i



# MEM ORA ND UM OP INION No. 04-10-00433- CV IN RE Jame s P LA CE an d G e r r y SAUM Orig inal Mandamus Proce eding 1 

## PER C URIAM Sitt ing: Kar en Ang elini, J ustice

Phylis J . Speedlin, J ustice Steven C. Hilbig, Just ice Deliver ed and F iled: J une 16, 2010 PETI T I O N F O R W RI T O F M A N D A M U S A

N D PE T I T I O N F O R W RI T O F PR O H I BI TI ON DENI ED On J une 4, 2010, re lators filed a petition for writ of manda mus and a p et i tion for writ of prohibition, and on J une 7, 2010 filed a “F irst Supplemental Motion for Em er gen cy Tempora ry Orde rs.” The court ha s considere d relator’s p et i t i o n s and is of the opinion that relators are not entitled to the relief soug ht. Acc ording ly , the petition for wr it of mandamus, the petition for writ of prohibition, and the emer g ency motion are DEN I ED. See T EX 

## . R. A PP 

## . P. 52.8(a). PER CU RIAM
Exhibit 31.2

CERTIFICATIONS

I, Kellie D. Nelsen, certify that:

1.

I have reviewed this Form 10-QSB of Hypertension Diagnostics, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

4.

The small business issuers other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the small business issuers disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the small business issuers internal control over financial reporting that occurred during the small business issuers most recent fiscal quarter (the small business issuers fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuers internal control over financial reporting; and

5.

The small business issuers other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuers auditors and the audit committee of the small business issuers board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuers ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuers internal control over financial reporting.



Date:  November 14, 2006

/s/ Kellie D. NelsenKellie D. Nelsen
Manager of Finance and Accounting (principal financial officer)
### Proposed Provision: E3.18. Increase the taxable maximum linearly over 4 years to $279,900 for 2028. After 2028, index the taxable maximum to AWI plus 0.5 percentage point. Apply benefit credit on additional earnings taxed.

back